首页> Frontiers in oncology> Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α.

Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α.

导出 LinkOut

翻译打印收藏纠错

第一作者： Wenzhao,Luo

第一单位： Henan University of Chinese Medicine, School of Basic Medicine (Zhongjing School), Zhengzhou, Henan, China.;Henan Province Hospital of Traditional Chinese Medicine, Department of Hepatobiliary and Spleen Stomach, Zhengzhou, Henan, China.

作者： Wenzhao,Luo ^[1] ; Xian,Li ^[2] ; Yiwan,Shang ^[3] ; Zhen,Chen ^[4] ; Yinglin,Cui ^[2]

作者单位： Henan University of Chinese Medicine, School of Basic Medicine (Zhongjing School), Zhengzhou, Henan, China.;Henan Province Hospital of Traditional Chinese Medicine, Department of Hepatobiliary and Spleen Stomach, Zhengzhou, Henan, China. ^[1] Henan Province Hospital of Traditional Chinese Medicine, Department of Hepatobiliary and Spleen Stomach, Zhengzhou, Henan, China. ^[2] Henan University of Chinese Medicine, School of Basic Medicine (Zhongjing School), Zhengzhou, Henan, China.;Henan University of Chinese Medicine, Academy of Chinese Medical Sciences, Zhengzhou, Henan, China. ^[3] Henan University of Chinese Medicine, Academy of Chinese Medical Sciences, Zhengzhou, Henan, China. ^[4]

关键词 FOXP3 NOTCH1 Xuanfu Hua hepatocellular carcinoma sorafenib

DOI 10.3389/fonc.2025.1552480

PMID 40444091

发布时间 2025-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交